ClinicalTrials.Veeva

Menu

Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study

A

Aristotle University Of Thessaloniki

Status

Enrolling

Conditions

Gynaecologic Cancer
ERAS
Laparotomy Patients
Excercise
Gynaecological Oncology
Quality of Life (QOL)
Compliance
Surgical Complication
Gynaecological Malignancies
Immunonutrition
Post Operative Pain

Treatments

Dietary Supplement: Ocoxin
Procedure: Structured self-guided exercise

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT07210164
337/2025, 18.09.2025

Details and patient eligibility

About

ERAS (Enhanced Recovery After Surgery) protocols are step-by-step care plans that help patients recover faster after surgery. They focus on keeping the body's normal functions, lowering stress from surgery, and supporting a quicker recovery. In gynecologic cancer surgeries, ERAS has been shown to help patients do better, have fewer problems, and leave the hospital sooner.

A prehabilitation program, in combination with ERAS protocols, aims to optimize patients' physical and psychological condition prior to surgery for gynecological cancers. Interventions may include tailored exercise, nutritional support, respiratory training, and psychological preparation. By enhancing baseline fitness and resilience, prehabilitation improves the body's ability to tolerate surgical stress, reduces complications, and facilitates a faster, smoother recovery within the ERAS framework.

Full description

The purpose of this study is to investigate the impact of multifactorial preoperative empowerment (pre-habilitation protocol) on patients with gynecological cancer who undergo oncological surgery. The objective of this study is to demonstrate whether the implementation of pre-habilitation program empowerment as opposed to its non-implementation leads to an improvement in quality of life, a reduction in days of hospitalization, a reduction in immediate (up to discharge) and long term (up to 40th post-surgery day) postoperative complications (as measured with the Clavien Dindo system), a reduction in hospital readmission rates, and postoperative morbidity and mortality.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type of gynecological malignancy: endometrial cancer, ovarian cancer, cervical cancer, treated with laparotomy after the decision of the gynecological-oncology unit (positive opinion of the Multidisciplinary Tumor Board - MDT)
  • Patient age: 18 to 85 years
  • General condition of the patient: ASA score I-III
  • Consent to implement the accelerated recovery protocol - Enhanced recovery after surgery (ERAS)
  • Sufficient understanding of the Greek language
  • Provision of signed, after thorough information, consent to participate in the study

Exclusion criteria

  • Women with performance status: ECOG >2 and ASA score >III
  • Women who have not been informed and have given written consent

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Prehabilitation group
Experimental group
Description:
This group undergo a structured preoperative self-guided exercise protocol (consisting of mild physical activity with a defined exercise program, respiratory exercise, muscle strengthening), immunonutrition (Ocoxin©) and usual clinical practice (stopping alcohol, regulating anemia and glucose levels). During the period of hospitalatization adhere to the 21-point ERAS protocol .
Treatment:
Procedure: Structured self-guided exercise
Dietary Supplement: Ocoxin
Control group
No Intervention group
Description:
This group follow the usual clinical practice (stopping alcohol, regulating anemia and glucose levels). During the period of hospitalatization adhere to the 21-point ERAS protocol .

Trial contacts and locations

1

Loading...

Central trial contact

Dimitrios Tsolakidis C. MD, PhD, Professor OB&GYN; Panagiotis Tzitzis M. MD, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems